Overactivity of tumor necrosis factor-alpha but not interleukin 6 is associated with low natural killer cytotoxic activity in the elderly

被引:0
作者
Mysliwska, J [1 ]
Bryl, E [1 ]
Zorena, K [1 ]
Balon, J [1 ]
Foerster, J [1 ]
Mysliwski, A [1 ]
机构
[1] GERIATR OUTPATIENTS DEPT,GDANSK,POLAND
关键词
ageing; natural killer cytotoxic activity; tumor necrosis factor-alpha; interleukin-6;
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
In this paper we asked whether the increased production of two proinflammatory cytokines - tumor necrosis factor-alpha (TNF alpha) and interleukin-6 (IL6) in the absence of the inflammatory stimulus, a phenomenon frequently occurring in the elderly, may contribute to the decrease of natural killer (NK) cytotoxic activity. NK cell activity is a part of a nonspecific immunity directed against infected and transformed cells. Wie measured the levels of bioactive TNF alpha and IL6 during cytotoxic NK reactions:and analyzed the effect of neutralizing monoclonal antibodies anti-TNF alpha and anti-IL6 on the outcome of cytotoxic reaction. Bioactive TNF alpha was produced in higher amounts during cytotoxic reactions of the elderly with low NK activity in comparison with its production by the elderly with high NK activity, Anti-TNF alpha decreased already low cytotoxic responses of the elderly while not having an effect on the cytotoxics potential of high responders. More of the bioactive IL6 was released during cytotoxic reactions of the elderly as compared with young people. There was, however, no relation between the height of NK cytotoxic activity and the amount of IL6. Our results suggest that the Increased level of TNF alpha seen in the elderly low NK responders may pose a compensatory mechanism, necessary ro keep the highest possible level of NK responses. The increased bioactivity of IL6 during NK reaction of the elderly does not seem to participate In the regulation of the level of NK cytotoxic activity.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 30 条
[1]  
BENDER BS, 1986, J CLIN LAB IMMUNOL, V21, P31
[2]   ESTABLISHMENT OF THE ROLE OF IL-6 AND TNF RECEPTOR-1 USING GENE KNOCKOUT MICE [J].
BLUETHMANN, H ;
ROTHE, J ;
SCHULTZE, N ;
TKACHUK, M ;
KOEBEL, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (05) :565-570
[3]   GAMMA-INTERFERON, INTERLEUKIN-4 AND INTERLEUKIN-6 IN-VITRO PRODUCTION IN OLD SUBJECTS [J].
CANDORE, G ;
DILORENZO, G ;
MELLUSO, M ;
CIGNA, D ;
COLUCCI, AT ;
MODICA, MA ;
CARUSO, C .
AUTOIMMUNITY, 1993, 16 (04) :275-280
[4]   PATHO-PHYSIOLOGY OF THE IMMUNE-SYSTEM IN ELDERLY SUBJECTS WITH OR WITHOUT DIABETES AND VARIATIONS AFTER RECOMBINANT INTERLEUKIN-2 [J].
CARNAZZO, G ;
MIRONE, G ;
TURTURICI, A ;
FAVETTA, A ;
CAMPO, ME ;
COSENZA, C ;
CHIARENZA, G ;
STIVALA, F .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1989, 9 (02) :163-180
[5]  
ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225
[6]  
FACCHINI A, 1987, CLIN EXP IMMUNOL, V68, P340
[7]   INCREASED CYTOKINE PRODUCTION IN MONONUCLEAR-CELLS OF HEALTHY ELDERLY PEOPLE [J].
FAGIOLO, U ;
COSSARIZZA, A ;
SCALA, E ;
FANALESBELASIO, E ;
ORTOLANI, C ;
COZZI, E ;
MONTI, D ;
FRANCESCHI, C ;
PAGANELLI, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2375-2378
[8]  
FUJIWARA T, 1992, J IMMUNOL, V148, P2941
[9]   INTERLEUKIN-6 ENHANCES THE INDUCTION OF HUMAN LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
GALLAGHER, G ;
STIMSON, WH ;
FINDLAY, J ;
ALAZZAWI, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (01) :49-52
[10]   INFLUENCE OF AGE ON HUMAN MARROW [J].
GLOWACKI, J .
CALCIFIED TISSUE INTERNATIONAL, 1995, 56 :S50-S51